When a non-diabetic journalist reviewed the Dexcom G6 continuous glucose monitor (CGM) for Business Insider, it sparked significant reactions within the diabetes community. The journalist, Lydia Ramsey, used the device to track her glucose levels over a few weeks, including during her participation in the NYC Marathon. While she acknowledged not being the intended user of a CGM, her article was seen by many in the diabetes community as shallow and disrespectful to the daily struggles faced by people with diabetes (PWDs). Some worried that her portrayal of the CGM as a general health gadget could lead insurers to view it as a non-essential luxury item. Despite the backlash, the article highlighted the potential for CGMs to become more mainstream, possibly benefiting a broader audience, including PWDs, by making the technology more accessible and affordable.